Trial
NCT04342897
A Study of LY3127804 in Participants With COVID-19
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
COVID-19
Intervention
LY3127804
Why stopped
Trial terminated for futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-12